Status:
COMPLETED
Time Efficiency Comparison of Two IntraVitreal Injection Techniques
Lead Sponsor:
Peregrine Eye and Laser Institute
Conditions:
Neovascular Age-related Macular Degeneration
Diabetic Macular Edema
Eligibility:
All Genders
21+ years
Phase:
NA
Brief Summary
Prospective, single-center, randomized, clinical trial (RCT) comparing the time efficiency and safety of a single-use intravitreal injection (IVI) guide versus a traditional technique using a dual bla...
Detailed Description
Prospective, single-center, randomized, clinical trial (RCT) comparing the efficiency and safety of a single-use IIG with a traditional technique using a dual blade speculum among patients undergoing ...
Eligibility Criteria
Inclusion
- \* Eyes of adult patients requiring intravitreally injected medications for non-infectious indications
Exclusion
- History of extraocular or intraocular infection within 3 months of the scheduled IVI date
- Scleral thinning
- History of previous glaucoma surgery
- History of pars plana vitrectomy
- Hypersensitivity to the IVI drug, proparacaine or povidone iodine
- Inability to understand the informed consent form
Key Trial Info
Start Date :
November 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 9 2021
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04455399
Start Date
November 9 2020
End Date
January 9 2021
Last Update
April 27 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peregrine Eye and Laser Instittute
Makati City, MM, Philippines, 1209